Tubize-Fin
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affects immune system or central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.
Tubize-Fin (TUB) - Total Liabilities
Latest total liabilities as of June 2025: €367.02K EUR
Based on the latest financial reports, Tubize-Fin (TUB) has total liabilities worth €367.02K EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tubize-Fin - Total Liabilities Trend (2000–2024)
This chart illustrates how Tubize-Fin's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Tubize-Fin Competitors by Total Liabilities
The table below lists competitors of Tubize-Fin ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mueller Water Products
NYSE:MWA
|
USA | $828.60 Million |
|
Grand Canyon Education Inc
NASDAQ:LOPE
|
USA | $245.37 Million |
|
BB Seguridade Participacoes SA
PINK:BBSEY
|
USA | $7.57 Billion |
|
Iveco Group
OTCGREY:IVCGF
|
USA | $15.10 Billion |
|
Hongfa Technology Co Ltd
SHG:600885
|
China | CN¥8.34 Billion |
|
Magnolia Oil & Gas Corp
NYSE:MGY
|
USA | $917.17 Million |
|
Li Ning Company Limited
PINK:LNNGF
|
USA | $9.61 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down Tubize-Fin's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tubize-Fin's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tubize-Fin (2000–2024)
The table below shows the annual total liabilities of Tubize-Fin from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €89.28 Million | -27.80% |
| 2023-12-31 | €123.65 Million | +41.82% |
| 2022-12-31 | €87.19 Million | +316.40% |
| 2021-12-31 | €20.94 Million | -38.88% |
| 2020-12-31 | €34.26 Million | -60.83% |
| 2019-12-31 | €87.46 Million | -39.28% |
| 2018-12-31 | €144.04 Million | -26.38% |
| 2017-12-31 | €195.65 Million | -26.24% |
| 2016-12-31 | €265.26 Million | -14.94% |
| 2015-12-31 | €311.84 Million | +46.03% |
| 2014-12-31 | €213.55 Million | -15.67% |
| 2013-12-31 | €253.23 Million | -13.73% |
| 2012-12-31 | €293.53 Million | -8.36% |
| 2011-12-31 | €320.31 Million | -6.06% |
| 2010-12-31 | €340.97 Million | -7.00% |
| 2009-12-31 | €366.64 Million | -5.97% |
| 2008-12-31 | €389.92 Million | -5.77% |
| 2007-12-31 | €413.79 Million | +72.19% |
| 2006-12-31 | €240.31 Million | +104.48% |
| 2005-12-31 | €117.52 Million | -4.22% |
| 2004-12-31 | €122.70 Million | -21.41% |
| 2003-12-31 | €156.12 Million | -8.94% |
| 2002-12-31 | €171.45 Million | +33.07% |
| 2001-12-31 | €128.84 Million | +57.37% |
| 2000-12-31 | €81.87 Million | -- |